{
    "root": "313fd56f-b10b-b499-e063-6294a90a2912",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Amlodipine Besylate",
    "value": "20250326",
    "ingredients": [
        {
            "name": "ANHYDROUS DIBASIC CALCIUM PHOSPHATE",
            "code": "L11K75P92J"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U"
        },
        {
            "name": "SODIUM STARCH GLYCOLATE TYPE A POTATO",
            "code": "5856J3G2A2"
        },
        {
            "name": "AMLODIPINE BESYLATE",
            "code": "864V2Q084H"
        }
    ],
    "indications": "Amlodipine besylate tablets are a calcium channel blocker and may be used alone or in combination with other antihypertensive and antianginal agents for the treatment of: Hypertension ( 1.1 ) Amlodipine besylate tablets are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. Coronary Artery Disease ( 1.2 ) Chronic Stable Angina Vasospastic Angina (Prinzmetal’s or Variant Angina) Angiographically Documented Coronary Artery Disease in patients without heart failure or an ejection fraction < 40%",
    "contraindications": "Adult recommended starting dose: 5 mg once daily with maximum dose 10 mg once daily. ( 2.1 ) Small, fragile, or elderly patients, or patients with hepatic insufficiency may be started on 2.5 mg once daily. ( 2.1 ) Pediatric starting dose: 2.5 mg to 5 mg once daily. ( 2.2 ) Important Limitation: Doses in excess of 5 mg daily have not been studied in pediatric patients. ( 2.2 )",
    "warningsAndPrecautions": "Amlodipine besylate tablets USP are available as follows:\n                  \n                     2.5 mg Tablets\n                  \n                  2.5 mg (equivalent to 2.5 mg of amlodipine per tablet) - white to off-white, round, standard convex tablets, debossed with the number “93” on one side and “83” on the other side of the tablet and supplied as follows:\n                  NDC 42291-025-10 Bottles of 1000\n                  \n                     \n                  \n                  \n                     5 mg Tablets\n                  \n                  5 mg (equivalent to 5 mg of amlodipine per tablet) - white to off-white, round, standard convex tablets, debossed with the number “93” on one side and “7167” on the other side of the tablet and supplied as follows:\n                  NDC 42291-026-10 Bottles of 1000\n                  \n                  \n                     10 mg Tablets\n                  \n                  10 mg (equivalent to 10 mg of amlodipine per tablet) - white to off-white, round, standard convex tablets, debossed with the number “93” on one side and “7168” on the other side of the tablet and supplied as follows:\n                  NDC 42291-027-90 Bottles of 90 \n    NDC 42291-027-10 Bottles of 1000\n \n                  \n                  \n                     Storage\n                  \n                  Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature].\n                  Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure (as required).\n                  KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN.\n                  Manufactured for: \n    AvKARE \n    Pulaski, TN 38478\n \n                  Mfg. Rev. 03/22 \n    AV 06/23 (P)",
    "adverseReactions": "Amlodipine besylate tablets are contraindicated in patients with known sensitivity to amlodipine."
}